0
0.5
1
1.5
2+
Symp. case
-60%
Improvement
Relative Risk
Symp. case (b)
-110%
Symp. case (c)
16%
Case
-92%
Case (b)
-137%
Case (c)
-21%
HCQ Syed et al. Prophylaxis RCT
Is pre-exposure prophylaxis with HCQ beneficial for COVID-19?
RCT 101 patients in Pakistan (May - September 2020)
More symptomatic cases (p=0.41) and cases (p=0.12), not sig.
c19hcq.org
Syed et al., Cureus, May 2021
Favors HCQ
Favors control